New England Securities Corporation »

SPDR S&P Biotech shares owned by New England Securities Corporation

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by New England Securities Corporation from 13F filings

Historical chart of New England Securities Corporation investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by New England Securities Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by New England Securities Corporation

Quarter filed Position value Share count Share price at filing
2014-12-31 $642k 3.4k 186.30
2014-09-30 $516k 3.3k 155.94
2014-06-30 $571k 3.7k 153.91
2014-03-31 $447k 3.1k 142.36
2013-12-31 $401k 3.1k 130.11
2013-09-30 $346k 2.7k 129.06
2013-06-30 $281k 2.7k 104.38

More positions owned by New England Securities Corporation

Spdr S&p 500 Etf (SPY)
Vanguard Dividend Appreciation ETF (VIG)
Parsley Energy Inc-class A
SPDR S&P Dividend (SDY)
Apple (AAPL)
iShares Russell 1000 Growth Index (IWF)
Rydex S&P 500 Pure Growth ETF
Vanguard FTSE All-World ex-US ETF (VEU)
WisdomTree LargeCap Dividend Fund (DLN)
iShares Russell Midcap Index Fund (IWR)
PowerShares Dynamic Pharmaceuticals
iShares MSCI EAFE Index Fund (EFA)
Vanguard Growth ETF (VUG)
Vanguard Small-Cap Growth ETF (VBK)
iShares S&P MidCap 400 Growth (IJK)

View all positions for New England Securities Corporation

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities

View all funds holding SPDR S&P Biotech